Literature DB >> 20970753

Paradoxically high adiponectin and the healthy obese phenotype in obese black and white 16-year-old girls.

John A Morrison1, Charles J Glueck, Stephen Daniels, Ping Wang, Paul Horn, Davis Stroop.   

Abstract

Although adiponectin is correlated inversely with obesity, some obese adults without metabolic complications of obesity have paradoxically high adiponectin. Therefore, we assessed adiponectin risk factor relations in 133 obese 16-year-old school girls from a cohort of 448, focusing on paradoxically high adiponectin-risk in obesity and the healthy obese phenotype. Median adiponectin (11.9 mg/L) in nonobese girls (body mass index [BMI] < 24.6 kg/m²) was selected as a cutpoint to identify high adiponectin in obese girls. Of 90 black and 43 white obese girls (BMI ≥ 24.6), 25 black (28%) and 13 white (30%) girls had paradoxically high adiponectin (>11.9). The 38 obese girls with adiponectin >11.9 versus the 95 obese girls with adiponectin ≤11.9 had higher median high-density lipoprotein (HDL) cholesterol (54 vs 46 mg/dL, P = 0.0007) and apolipoprotein A1 (ApoA1) (181 vs 164 mg/dL, P = 0.011) and had lower insulin (14 vs 20 uU/mL, P = 0.0006). In the 133 obese girls, through stepwise regression, the adiponectin category (>11.9, ≤ 11.9 mg/L) was a significant independent positive determinant of HDL cholesterol (partial r² = 8.4%, P = 0.001), ApoA1 (partial r² = 4.1%, P = 0.025), and it was associated inversely with fasting serum insulin (partial r² = 5.4%, P = 0.0074). By stepwise logistic regression in the 133 obese girls, the adiponectin category (high vs low) was a significant inverse explanatory variable for metabolic syndrome (odds ratio 0.20, 95% confidence intervals 0.04-0.95, P = 0.043). We conclude that paradoxically high adiponectin is associated with the healthy obese phenotype in obese adolescent black and white girls.
Copyright © 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970753      PMCID: PMC2978533          DOI: 10.1016/j.trsl.2010.08.003

Source DB:  PubMed          Journal:  Transl Res        ISSN: 1878-1810            Impact factor:   7.012


  34 in total

1.  More powerful procedures for multiple significance testing.

Authors:  Y Hochberg; Y Benjamini
Journal:  Stat Med       Date:  1990-07       Impact factor: 2.373

2.  Can we identify metabolically healthy but obese individuals (MHO)?

Authors:  A D Karelis; M Brochu; R Rabasa-Lhoret
Journal:  Diabetes Metab       Date:  2004-12       Impact factor: 6.041

3.  Heart disease risk among metabolically healthy obese men and metabolically unhealthy lean men.

Authors:  Ian Janssen
Journal:  CMAJ       Date:  2005-05-10       Impact factor: 8.262

4.  2000 CDC Growth Charts for the United States: methods and development.

Authors:  Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson
Journal:  Vital Health Stat 11       Date:  2002-05

5.  The metabolically healthy but obese individual presents a favorable inflammation profile.

Authors:  Antony D Karelis; May Faraj; Jean-Philippe Bastard; David H St-Pierre; Martin Brochu; Denis Prud'homme; Remi Rabasa-Lhoret
Journal:  J Clin Endocrinol Metab       Date:  2005-04-26       Impact factor: 5.958

6.  Obesity evaluation and treatment: Expert Committee recommendations. The Maternal and Child Health Bureau, Health Resources and Services Administration and the Department of Health and Human Services.

Authors:  S E Barlow; W H Dietz
Journal:  Pediatrics       Date:  1998-09       Impact factor: 7.124

7.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

8.  Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study.

Authors: 
Journal:  Am J Public Health       Date:  1992-12       Impact factor: 9.308

9.  Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

Authors:  Joan Vendrell; Montserrat Broch; Nuria Vilarrasa; Ana Molina; Jose Manuel Gómez; Cristina Gutiérrez; Immaculada Simón; Joan Soler; Cristóbal Richart
Journal:  Obes Res       Date:  2004-06

10.  A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome.

Authors:  Claudia Menzaghi; Tonino Ercolino; Rosa Di Paola; Anders H Berg; James H Warram; Philipp E Scherer; Vincenzo Trischitta; Alessandro Doria
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  6 in total

1.  Development of metabolic syndrome in high-sucrose diet fed rats is not associated with decrease in adiponectin levels.

Authors:  M Aslam; S V Madhu
Journal:  Endocrine       Date:  2017-09-06       Impact factor: 3.633

2.  Paradoxical Hyperadiponectinemia is Associated With the Metabolically Healthy Obese (MHO) Phenotype in African Americans.

Authors:  Ayo P Doumatey; Amy R Bentley; Jie Zhou; Hanxia Huang; Adebowale Adeyemo; Charles N Rotimi
Journal:  J Endocrinol Metab       Date:  2012-04-01

3.  Adiponectin circulating levels and 10-year (2002-2012) cardiovascular disease incidence: the ATTICA Study.

Authors:  Ioannis Kyrou; Olga Tsantarlioti; Demosthenes B Panagiotakos; Constantine Tsigos; Ekavi Georgousopoulou; Christina Chrysohoou; Ioannis Skoumas; Dimitrios Tousoulis; Christodoulos Stefanadis; Christos Pitsavos
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

4.  Serum ZAG and Adiponectin Levels Were Closely Related to Obesity and the Metabolically Abnormal Phenotype in Chinese Population.

Authors:  Meijuan Liu; Kun Zhang; Linjie Wang; Hongbo Yang; Kemin Yan; Hui Pan; Huijuan Zhu; Fengying Gong
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-26       Impact factor: 3.168

5.  Adiponectin Levels Differentiate Metabolically Healthy vs Unhealthy Among Obese and Nonobese White Individuals.

Authors:  Scott Ahl; Mitchell Guenther; Shi Zhao; Roland James; Jacqueline Marks; Aniko Szabo; Srividya Kidambi
Journal:  J Clin Endocrinol Metab       Date:  2015-09-24       Impact factor: 5.958

6.  Role of plasma adiponectin /C-reactive protein ratio in obesity and type 2 diabetes among African Americans.

Authors:  Preetha Anna Abraham; Selasi Attipoe; Josh B Kazman; Stacey Anne Zeno; Merrily Poth; Patricia Anne Deuster
Journal:  Afr Health Sci       Date:  2017-03       Impact factor: 0.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.